Evidence map›Paper›PMID 28449366›Full record

ReviewJournal of neurochemistry2017

Moving forward with the neuromuscular junction.

Claire Legay, Lin Mei

Abstract readReview
In one paragraph

Review in Journal of neurochemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. The Neuromuscular Junction: A Shared Vulnerability in Aging and Disease.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Review
  2. Article
  3. Article
  4. Review
  5. Deletion of Transferrin Receptor 1 in Parvalbumin Interneurons Induces a Hereditary Spastic Paraplegia-Like Phenotype.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  6. Article
  7. Optimization of Application-Driven Development ofTissue engineering. Part B, Reviews · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Mechanical regulation of musculoskeletal system development.Development (Cambridge, England) · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Claire LegayUniversité Paris Descartes, CNRS UMR 8119, Sorbonne Paris Cité, Paris, France.
Lin MeiDepartment of Neurosciences and Regenerative medicine, Charlie Norwood VA Medical Center, Augusta, Georgia, USA.

Funding

Mechanisms of neuromuscular junction formationR01NS082007 · NINDS · CASE WESTERN RESERVE UNIVERSITY · PI XIONG, WEN-CHENG · 2013 to 2022
$5.2M
SIGNALING MECHANISMS REGULATING ACHR SYNTHESIS AT NMJR01NS040480 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MEI, LIN · 2000 to 2013
$3.6M
Characterization of Agrin/LRP4 Antibody-Positive Myasthenia GravisR01NS090083 · NINDS · CASE WESTERN RESERVE UNIVERSITY · PI MEI, LIN · 2015 to 2019
$2.9M
Swedish APP mutation and NMJ decline in Alzheimer's diseaseR01AG051510 · NIA · CASE WESTERN RESERVE UNIVERSITY · PI XIONG, WEN-CHENG, ZIGMOND, RICHARD E · 2015 to 2024
$2.6M
Neuromuscular Junction FormationR01NS056415 · NINDS · AUGUSTA UNIVERSITY · PI MEI, LIN · 2008 to 2011
$1.4M
NIA NIH HHS R01 AG051510NINDS NIH HHS R01 NS040480NINDS NIH HHS R01 NS056415NINDS NIH HHS R01 NS082007NINDS NIH HHS R01 NS090083
6 · The paper itself

Abstract

The neuromuscular junction (NMJ) is indispensable for survival. This synapse between motoneurons and skeletal muscle fibers allows posture, movement and respiration. Therefore, its dysfunction creates pathologies than can be lethal. The molecular mechanisms of NMJ development and maintenance are the subject of intensive studies. This mini-review focuses on some of the most recent discoveries. An unexpected role for a protein, rapsyn, which has been known for 40 years to aggregate acetylcholine receptors has emerged. A new cell partner at NMJ has been unmasked and is challenging our understanding of the functioning of this synapse. Toxins are now used as new tools to study degeneration/regeneration. The possibility of creating human NMJ in vitro is within reach with major consequences for drug screening. Wnts are secreted neurogenic factors that have been involved in vitro in acetylcholine receptor clustering, but their precise role in vivo remains to be clarified. All these data are raising new and exciting perspectives in the field and are discussed in this Review. This is an article for the special issue XVth International Symposium on Cholinergic Mechanisms.

Indexed as

AnimalsCell DifferentiationHumansMembrane ProteinsMuscle, SkeletalNeuromuscular JunctionReceptors, CholinergicSynapsesMembrane ProteinsReceptors, Cholinergicacetylcholine receptorcongenital myasthenic syndromeslatrotoxinnerve degenerationneuromuscular junctionrapsynsympathetic neuronWnts

Identifiers

PMID28449366
PMCPMC6029705

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.